Latest News about BMRN
Recent news which mentions BMRN
   12 biotech stocks to consider buying now as prospects for the sector brighten this year
   
  
  
  February 06, 2022
  From MarketWatch
 
   2 Under-the-Radar Biotech Picks to Buy For The Long Haul
   
  
  
  December 24, 2021
  From Motley Fool
 
   This Favorable Sign Appears On Biomarin Pharmaceutical's Chart
   
  November 25, 2021
  Tickers 
   BMRN
  
  
  From Benzinga
 
   Hopeful Golden Cross Forms On Biomarin Pharmaceutical's Chart
   
  November 24, 2021
  Tickers 
   BMRN
  
  
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For November 22, 2021
   
  
  
  November 22, 2021
  From Benzinga
 
   10 Biggest Price Target Changes For Monday
   
  
  
  November 22, 2021
  From Benzinga
 
   Why BioMarin Pharmaceutical Stock Jumped by 10.3% on Friday
   
  November 20, 2021
  Tickers 
   BMRN
  
  
  From Motley Fool
 From Benzinga
 
   The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
   
  
  
  November 14, 2021
  From Benzinga
 
   Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
   
  
  
  November 02, 2021
  From Benzinga
 
   BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcript
   
  October 28, 2021
  Tickers 
   BMRN
  
  
  From Motley Fool
 
   The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
   
  
  
  October 24, 2021
  From Benzinga
 
   2 Upcoming FDA Approval Decisions That Investors Should Really Watch
   
  
  
  October 23, 2021
  From Motley Fool
 
   The Smartest Stocks to Buy With $250 Right Now
   
  
  
  October 22, 2021
  From Motley Fool
 From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
   
  
  
  September 09, 2021
  From Benzinga
 
   Price To Earnings Ratio Insights For Biomarin Pharmaceutical
   
  September 07, 2021
  Tickers 
   BMRN
  
  
  From Benzinga
 
   12 Health Care Stocks Moving In Tuesday's Pre-Market Session
   
  
  
  September 07, 2021
  From Benzinga
 
   FDA Slaps Clinical Hold on BioMarin's Gene Therapy For Genetic Metabolism Disorder
   
  September 07, 2021
  Tickers 
   BMRN
  
  
  From Benzinga
 
   Get Ready for a Potential Double in This Biopharmaceutical Stock in the Next 6 to 12 Months
   
  
  
  August 20, 2021
  From Motley Fool
 Tickers 
   BMRN
  
  
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.